ブルーバード・バイオのニュース一覧

Investor Optimism Abounds Bluebird Bio, Inc. (NASDAQ:BLUE) But Growth Is Lacking

Simply Wall St12/13 21:07

Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

Benzinga12/13 08:50

Reported Sunday, Bluebird Bio Highlights 9-Year Data For LYFGENIA Gene Therapy: Sustained Benefits In Sickle Cell Disease Patients At ASH 2024

Benzinga12/09 15:48

Bluebird Bio Announced Long-Term Follow-Up Data Continue To Support Beti-Cel As Potentially Curative Gene Therapy For Β-Thalassemia Patients Who Require Regular Transfusions Through Achievement Of Durable Transfusion Independence And Normal Or...

Benzinga12/08 04:30

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga12/06 05:05

Bluebird Bio Announces 1-for-20 Reverse Stock Split

Businesswire12/05 05:05

FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program

Benzinga12/05 03:31

Bluebird Bio Shares Are Trading Higher After the Company Announced It Joined the CMMI Cell and Gene Therapy Access Model and Will Offer Outcomes-based Agreements to Expand Medicaid Access to LYFGENIA Gene Therapy for Sickle Cell Disease.

Benzinga12/05 03:23

CMS Rolls Out New Payment Model for Vertex, Bluebird Gene Therapies

Seeking Alpha12/05 01:40

Bluebird Bio Shares Are Trading Lower After the FDA Announced an Investigation Into a Serious Risk of Hematologic Malignancy Following Skysona.

Benzinga11/28 02:50

FDA Investigating Safety Risks of Bluebird's Skysona

Seeking Alpha11/28 02:49

FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)

Benzinga11/28 00:35

Spotless Brands Expands Into Idaho and Oregon With Acquisitions of Bluebird Express Car Wash and Epic Shine Car Wash

PR Newswire11/19 23:00

ウェルズ・ファーゴはブルーバード・バイオ(BLUE.US)のレーティングを中立に据え置き、目標株価を2ドルに据え置いた

ウェルズ・ファーゴのアナリストYanan Zhuは$bluebird bio(BLUE.US)$のレーティングを中立に据え置き、目標株価を2ドルに据え置いた。TipRanksのデータによると、このアナリストの最近1年間の的中率は33.7%、平均リターンは10.1%である。また、$bluebird bio(BLUE.US)$の最近の主なアナリストの観点は以下の通りである：同社は、注入のタイミングに起

Futuニュース11/19 20:31

Bluebird Bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo Finance11/16 20:46

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires11/16 05:01

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

Benzinga11/16 03:05

RBC Capital Reiterates Sector Perform on Bluebird Bio, Maintains $4 Price Target

Analyst Upgrades11/16 01:47

Bluebird Bio Downgraded by Bank of America, Shares Tumble | NASDAQ:BLUE

Proactive Investors11/16 01:34

Bluebird Bio Extends Selloff as BofA and J.P. Morgan Cuts After Q3 Results

Seeking Alpha11/16 01:07